2 years ago
IRON
AnalystsBenjamin BurnettBenjamin Burnett's Stock Forecasts
AnalystsBenjamin Burnett
Sectors:
Analyst Ranking
Bottom 17%
#4303 out of 5124 analysts
Average Return
-0.28%
Win Rate
45%33 out of 74
Risk vs Reward
Poor
Good
Benjamin Burnett's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gracell Biotechnologies IncGRCL | +271.38% | $2.76 | $10.25 | 2023-10-18 - 2024-02-21 | Strong Buy |
Cti Biopharma CorpCTIC | +134.68% | $2.22 | $5.21 | 2021-05-05 - 2022-05-05 | Strong Buy |
Arcellx IncACLX | +134.31% | $30.11 | $70.55 | 2023-03-13 - 2024-03-13 | Strong Buy |
Revolution Medicines IncRVMD | +131.08% | $33.62 | $77.69 | 2025-03-31 - 2025-12-03 | Strong Buy |
Revolution Medicines IncRVMD | +98.80% | $39.08 | $77.69 | 2025-02-26 - 2025-12-03 | Strong Buy |
Benjamin Burnett Analyst Color
Get additional color on Benjamin Burnett's coverage of popular stocks
Benjamin Burnett's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Avadel Pharmaceuticals PLCAVDL | 3 | Hold | $22.50 | +5.34% | Maintains | 14 days ago |
Centessa Pharmaceuticals PLCCNTA | 3 | Strong Buy | $35.00 | +20.40% | Maintains | 21 days ago |
Alkermes PLCALKS | 3 | Strong Buy | $37.00 | +25.30% | Maintains | 21 days ago |
Wave Life Sciences LtdWVE | 1 | Strong Buy | $16.00 | +124.09% | Maintains | 23 days ago |
Mannkind CorpMNKD | 1 | Strong Buy | $8.00 | +43.11% | Maintains | 23 days ago |
Keros Therapeutics IncKROS | 1 | Strong Buy | $23.00 | +27.07% | Maintains | 23 days ago |
Ptc Therapeutics IncPTCT | 1 | Strong Buy | $93.00 | +22.76% | Maintains | a month ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $44.00 | -0.65% | Maintains | a month ago |
Axsome Therapeutics IncAXSM | 2 | Strong Buy | $157.00 | +6.22% | Maintains | a month ago |
United Therapeutics CorpUTHR | 1 | Hold | $423.00 | -12.05% | Maintains | a month ago |
Revolution Medicines IncRVMD | 5 | Strong Buy | $64.00 | -17.62% | Maintains | 8 months ago |
Fate Therapeutics IncFATE | 3 | Hold | $3.00 | +177.78% | Maintains | 9 months ago |
Crispr Therapeutics AgCRSP | 7 | Hold | $49.00 | -12.48% | Maintains | 10 months ago |
Disc Medicine IncIRON | 7 | Strong Buy | $94.00 | +1.75% | Maintains | 10 months ago |
Repare Therapeutics IncRPTX | 5 | Strong Buy | $4.00 | +84.33% | Maintains | a year ago |
Arcellx IncACLX | 5 | Strong Buy | $122.00 | N/A | Maintains | a year ago |
Beam Therapeutics IncBEAM | 2 | Strong Buy | $69.00 | N/A | Maintains | a year ago |
Ideaya Biosciences IncIDYA | 7 | Strong Buy | $68.00 | N/A | Maintains | a year ago |
Jasper Therapeutics IncJSPR | 1 | Strong Buy | $86.00 | N/A | Initiates Coverage On | a year ago |
Cabaletta Bio IncCABA | 3 | Strong Buy | $32.00 | N/A | Maintains | a year ago |
Precigen IncPGEN | 3 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Allogene Therapeutics IncALLO | 4 | Hold | $4.60 | N/A | Maintains | 2 years ago |
Atara Biotherapeutics IncATRA | 4 | Hold | $57.50 | N/A | Maintains | 2 years ago |
Kinnate Biopharma IncKNTE | 5 | Hold | $2.59 | N/A | Maintains | 2 years ago |
Gracell Biotechnologies IncGRCL | 2 | Hold | $10.25 | N/A | Downgrades | 2 years ago |
Mirati Therapeutics IncMRTX | 6 | Hold | $59.00 | N/A | Downgrades | 2 years ago |
Iovance Biotherapeutics IncIOVA | 9 | Strong Buy | $25.00 | N/A | Reiterates | 2 years ago |
Effector Therapeutics IncEFTR | 4 | Strong Buy | $175.00 | N/A | Upgrades | 3 years ago |
Cti Biopharma CorpCTIC | 2 | Hold | $9.10 | N/A | Downgrades | 3 years ago |
Neurogene IncNGNE | 2 | Hold | $4.50 | N/A | Downgrades | 3 years ago |
Global Blood Therapeutics IncGBT | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Genocea Biosciences IncGNCAQ | 1 | Hold | $0.16 | N/A | Downgrades | 4 years ago |
Precision Biosciences IncDTIL | 2 | Strong Buy | $780.00 | N/A | Maintains | 4 years ago |
Nektar TherapeuticsNKTR | 2 | Strong Buy | $360.00 | N/A | Upgrades | 4 years ago |
Sangamo Therapeutics IncSGMO | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 5 years ago |
Bluebird Bio IncBLUE | 3 | Strong Buy | $1,400.00 | N/A | Upgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.